Caroline C. Ennis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Caroline C. Ennis has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anna Park
Department of Biology, Coastal Carolina University, Conway, SC 29528-6054, USA
1 shared publication Austin C. Macdonald-Shedd
Department of Biological Sciences, 132 Long Hall, Clemson University, Clemson, SC 29634, USA
1 shared publication- Avery M. Savoie
Department of Biological Sciences, 132 Long Hall, Clemson University, Clemson, SC 29634, USA
1 shared publication Cameron D. Keyser
Department of Biological Sciences, 132 Long Hall, Clemson University, Clemson, SC 29634, USA
1 shared publication- Cassandra Millet-Boureima
Biology Department, Concordia University, Montreal, QC H4B 1R6, Canada
1 shared publication - Chiara Gamberi
Department of Biology, Coastal Carolina University, Conway, SC 29526, USA
1 shared publication
Latest Publications
- Open Access
Empowering Melatonin Therapeutics with Drosophila Models
Melatonin functions as a central regulator of cell and organismal function as well as a neurohormone involved in several processes, e.g., the regulation of the circadian rhythm, sleep, aging, oxidative response, and more. As such, it holds immense pharmacological potential. Receptor-mediated melatonin function mainly occurs through MT1 and MT2, conserved amongst mammals. Other melatonin-binding proteins exist. Non-receptor-mediated activities involve regulating the mitochondrial function and antioxidant cascade, which are frequently affected by normal aging as well as disease. Several pathologies display diseased or dysfunctional mitochondria, suggesting melatonin may be used therapeutically. Drosophila models have extensively been employed to study disease pathogenesis and discover new drugs. Here, we review the multiple functions of melatonin through the lens of functional conservation and model organism research to empower potential melatonin therapeutics to treat neurodegenerative and renal diseases.
Open AccessEmpowering Melatonin Therapeutics with Drosophila Models
Melatonin functions as a central regulator of cell and organismal function as well as a neurohormone involved in several processes, e.g., the regulation of the circadian rhythm, sleep, aging, oxidative response, and more. As such, it holds immense pharmacological potential. Receptor-mediated melatonin function mainly occurs through MT1 and MT2, conserved amongst mammals. Other melatonin-binding proteins exist. Non-receptor-mediated activities involve regulating the mitochondrial function and antioxidant cascade, which are frequently affected by normal aging as well as disease. Several pathologies display diseased or dysfunctional mitochondria, suggesting melatonin may be used therapeutically. Drosophila models have extensively been employed to study disease pathogenesis and discover new drugs. Here, we review the multiple functions of melatonin through the lens of functional conservation and model organism research to empower potential melatonin therapeutics to treat neurodegenerative and renal diseases.